For all we know, our finding presents the first evidence that GINS4 plays an important role in the carcinogenesis of glioma, providing a potential therapeutic target for the treatment of glioma and providing new hope for improving the survival and prognosis of glioma patients. The gene discussed is GINS4; the disease is central nervous system cancer.